← Leaderboards
Miaofen G Hu
Harvard University (Medical School)
$649,302
Attributed
$649,302
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$649,302 · 2
By mechanism
R21$489,500 · 1
F32$159,802 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- James Rheinwald$3,668,447
- Jose A Halperin$24,126,775
- Sam W Lee$15,278,254
- Athanasios I Zavras$1,682,051
- Randy C. Todd$335,536
Others in their field
Top investigators on “Cyclin Dependent Kinase”
- Piotr Sicinski · Dana-Farber Cancer Inst$34,197,830
- J. Alan Diehl · University Of Nebraska Medical Center$15,968,384
- David Owen Morgan · University Of California San Francisco$15,595,703
- David Heimbrook · Leidos Biomedical Research, Inc.$14,454,063
- Richard Assoian · University Of Pennsylvania$13,323,056
- E Premkumar Reddy · Temple University$13,091,088
Research focus
Cyclin Dependent KinaseCell Growth RegulationOral Pharyngeal NeoplasmTissue /Cell CultureHuman TissueCell CycleGrowth InhibitorsNeoplasm /Cancer GeneticsProtein Protein InteractionDna ReplicationPostdoctoral InvestigatorKeratinocyteCarcinogenesisCell AgingAntibodiesBrainBiochemicalAnti AgingAgingDesignCyclin-Dependent Kinase 6Beta-GalactosideClinical TrialsBenchmarking
Grant awards (5)
The role of CDK6 in Alzheimer's Disease$489,500
R21 · FY2023 · AG · contact PI
P12DOC-1 &CDK2 IN CELL CYCLE CONTROL &ORAL CANCER$29,706
F32 · FY2003 · DE
P12DOC-1 &CDK2 IN CELL CYCLE CONTROL &ORAL CANCER$26,332
F32 · FY2003 · DE
P12DOC-1 &CDK2 IN CELL CYCLE CONTROL &ORAL CANCER$54,352
F32 · FY2002 · DE
P12DOC-1 &CDK2 IN CELL CYCLE CONTROL &ORAL CANCER$49,412
F32 · FY2001 · DE